Leaflet TACHYBEN 100mg concentrate for solution for infusion

Indicated for: hypertension

Route of administration: infusion

Substance: urapidil (antihypertensive)

ATC: C02CA06 (Cardiovascular system | Antiadrenergic agents, peripherally acting | Alpha-adrenoreceptor antagonists)

Urapidil is a medication used in the treatment of hypertension, particularly in cases of hypertensive emergencies. It acts as an antagonist of alpha-1 adrenergic receptors and an agonist of serotonin 5-HT1A receptors, providing a rapid and controlled reduction in blood pressure.

Urapidil is administered intravenously in acute situations or orally for long-term hypertension management. The dosage and administration method are determined by the physician based on the severity of the condition and the patient's response to treatment.

Common side effects include dizziness, headache, nausea, and fatigue. In rare cases, allergic reactions or severe hypotension may occur. It is important to use urapidil under strict medical supervision, especially in patients with other cardiovascular conditions.

Urapidil is an effective medication for controlling hypertension, helping to reduce the risk of serious complications such as stroke or myocardial infarction.

General data about TACHYBEN 100mg

  • Substance: urapidil
  • Date of latest medicines list: 01-06-2026
  • Product code: W58331001
  • Concentration: 100mg
  • Pharmaceutical form: concentrate for solution for infusion
  • Quantity: 5
  • Product type: Generic medicine
  • Price: 204.08 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: CENEXI - FRANTA
  • Holder: EVER NEURO PHARMA GMBH - AUSTRIA
  • Number: 10555/2018/01
  • Shelf life: 3 years-after packing for marketing; dupa dilutie-se utlizeaza imediat

Concentrations available for urapidil

  • 100mg
  • 25mg
  • 25mg/5ml
  • 50mg
  • 50mg/10ml